IL6 and lymphopenia: Both of the cases developed progressive respiratory distress, cardiac dysfunction, and severe coagulation dysfunction after one week of treatment, accompanied by a progressive increase in serum levels of IL-6 and IFN-γ, lymphopenia, hypokalemia, hypoproteinemia, and coagulation dysfunction.